Copyright
©The Author(s) 2017.
World J Gastroenterol. Mar 28, 2017; 23(12): 2149-2158
Published online Mar 28, 2017. doi: 10.3748/wjg.v23.i12.2149
Published online Mar 28, 2017. doi: 10.3748/wjg.v23.i12.2149
Figure 6 Effects of B.
infantis CGMCC313-2 on OVA-induced airway inflammation. Lung tissues were obtained from the (C) prevention group and (D) pre-treatment group treated with B. infantis CGMCC313-2, and from (A) the normal control group and (B) the ovalbumin sensitized/challenged group on Day 29. The tissues were stained and observed under × 200 magnification. The positive control group showed severe airway inflammation, while the groups treated with B. infantis CGMCC313-2 showed attenuation of airway inflammation.
- Citation: Liu MY, Yang ZY, Dai WK, Huang JQ, Li YH, Zhang J, Qiu CZ, Wei C, Zhou Q, Sun X, Feng X, Li DF, Wang HP, Zheng YJ. Protective effect of Bifidobacterium infantis CGMCC313-2 on ovalbumin-induced airway asthma and β-lactoglobulin-induced intestinal food allergy mouse models. World J Gastroenterol 2017; 23(12): 2149-2158
- URL: https://www.wjgnet.com/1007-9327/full/v23/i12/2149.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i12.2149